GlassScriptPhysician profile
Hannah Stock
NPI 1144914946
$1,217.18
in general payments reported to CMS, 2019-2025
20 companies · $950 in 2025
The $950 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $267 · 2025: $950.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,117 · Education: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,117.18 |
| Education | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $169.27 | 2024-2025 | |
| Dendreon Pharmaceuticals LLC | $128.18 | 2024 | Provenge |
| Sumitomo Pharma America, INC. | $115.90 | 2024-2025 | Gemtesa, Orgovyx |
| Intuitive Surgical, INC. | $100.00 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $92.00 | 2025 | |
| Novartis Pharmaceuticals Corporation | $80.18 | 2025 | |
| Blue Earth Diagnostics | $69.16 | 2025 | Posluma |
| Teleflex LLC | $62.31 | 2024-2025 | Barrigel, Urolift |
| Janssen Biotech, INC. | $49.49 | 2025 | Erleada |
| Calyxo, INC. | $47.23 | 2025 | Cvac Aspiration System |
| Urogen Pharma, INC. | $46.13 | 2025 | |
| Astellas Pharma US INC | $45.54 | 2025 | Xtandi |
| Accord Healthcare, INC. | $45.34 | 2025 | |
| Coloplast Corp | $40.12 | 2025 | |
| Tolmar, INC. | $32.31 | 2025 | Eligard, Jatenzo |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $23.87 | 2025 | General - Therapies |
| Ferring Pharmaceuticals INC. | $21.38 | 2025 | Adstiladrin |
| Olympus America INC. | $19.45 | 2025 | Itind System |
| Myriad Genetic Laboratories, INC. | $16.00 | 2024 | Prolaris |
| Endo USA, INC. | $13.32 | 2024 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Stock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.